AnodeAI/Medical_genomics · Datasets at Hugging Face

patient_id stringlengths 12 12	record_id stringlengths 11 11	cancer_type stringclasses 1 value	histology stringclasses 3 values	stage_at_diagnosis stringclasses 3 values	driver_mutation stringclasses 7 values	pd_l1_tps_percent int64 5 41	tmb_mutations_per_mb float64 1.5 25	age_at_diagnosis int64 38 90	sex stringclasses 2 values	ecog_performance_status int64 0 4	smoking_pack_years int64 0 111	primary_tumor_size_cm float64 2 10	metastatic_sites_count int64 0 11	first_line_regimen stringclasses 6 values	overall_survival_months float64 4 83	censored bool 2 classes	msi_status stringclasses 2 values	record_generation_timestamp stringdate 2026-03-15 05:35:56 2026-03-15 05:36:02	synthetic_source stringclasses 1 value
ANODE_843269	REC_0010601	Non-small cell lung cancer	Large cell carcinoma	IVB	None (PD-L1 high)	30	5.8	65	female	1	12	3.8	9	pembrolizumab 200 mg q3w	9	true	MSS	2026-03-15T05:35:59.503138+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_396741	REC_0010602	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None (PD-L1 high)	17	7.6	64	female	1	56	6.7	4	pembrolizumab 200 mg q3w	11	false	MSS	2026-03-15T05:35:59.503368+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_266026	REC_0010603	Non-small cell lung cancer	Adenocarcinoma	III	ROS1 fusion	29	14	77	female	2	19	6.6	0	entrectinib 600 mg daily	31	true	MSS	2026-03-15T05:35:59.503604+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_697448	REC_0010604	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	20	10.3	63	male	1	14	5.2	6	sotorasib 960 mg daily	13.5	true	MSI-H	2026-03-15T05:35:59.503837+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_769368	REC_0010605	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	21	4.7	76	female	2	56	5.3	5	carboplatin + paclitaxel + pembrolizumab	4	true	MSS	2026-03-15T05:35:59.504109+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_969638	REC_0010606	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	20	16.9	73	male	2	23	5.2	6	osimertinib 80 mg daily	18.5	false	MSS	2026-03-15T05:35:59.504359+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_904395	REC_0010607	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	21	2.2	58	male	1	49	7	5	carboplatin + paclitaxel + pembrolizumab	11.1	false	MSS	2026-03-15T05:35:59.504598+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_428188	REC_0010608	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	18	6.6	69	female	1	0	6.9	5	entrectinib 600 mg daily	4.3	true	MSS	2026-03-15T05:35:59.504828+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_902621	REC_0010609	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	23	5.5	57	female	0	9	3.5	4	sotorasib 960 mg daily	11.6	true	MSS	2026-03-15T05:35:59.505142+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_522168	REC_0010610	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	24	17.6	68	male	1	21	6.2	1	alectinib 600 mg BID	19.4	false	MSS	2026-03-15T05:35:59.505383+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_761163	REC_0010611	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	21	14.8	73	female	1	13	3.8	4	osimertinib 80 mg daily	9.9	false	MSS	2026-03-15T05:35:59.505617+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_786217	REC_0010612	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	31	13.4	76	female	1	13	3.1	2	alectinib 600 mg BID	23.6	false	MSI-H	2026-03-15T05:35:59.505849+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_334661	REC_0010613	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	22	16.6	68	female	0	9	4.5	7	sotorasib 960 mg daily	12.7	false	MSS	2026-03-15T05:35:59.506087+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_752777	REC_0010614	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None	31	7.9	68	female	1	21	6	2	carboplatin + paclitaxel + pembrolizumab	11.7	false	MSS	2026-03-15T05:35:59.506316+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_506795	REC_0010615	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	29	16.1	67	female	0	14	7	4	osimertinib 80 mg daily	4	false	MSI-H	2026-03-15T05:35:59.506550+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_618129	REC_0010616	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	13	8.6	68	female	0	14	4.6	1	entrectinib 600 mg daily	22.1	true	MSS	2026-03-15T05:35:59.506780+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_666622	REC_0010617	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	18	11	75	male	2	4	7	5	sotorasib 960 mg daily	17.8	false	MSS	2026-03-15T05:35:59.507019+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_217721	REC_0010618	Non-small cell lung cancer	Adenocarcinoma	IVB	None (PD-L1 high)	17	11.7	47	female	0	21	5	7	pembrolizumab 200 mg q3w	14.1	false	MSI-H	2026-03-15T05:35:59.507251+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_859997	REC_0010619	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None (PD-L1 high)	32	6.6	71	male	0	34	6.9	5	pembrolizumab 200 mg q3w	17.8	true	MSS	2026-03-15T05:35:59.507483+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_400945	REC_0010620	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	28	14.7	68	female	1	28	4.2	2	entrectinib 600 mg daily	18.3	false	MSS	2026-03-15T05:35:59.507716+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_967130	REC_0010621	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	19	15.8	74	female	1	11	5.7	3	sotorasib 960 mg daily	15.2	false	MSI-H	2026-03-15T05:35:59.507950+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_966498	REC_0010622	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR L858R	21	14.9	68	female	0	16	5	1	osimertinib 80 mg daily	12.1	true	MSI-H	2026-03-15T05:35:59.508317+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_578510	REC_0010623	Non-small cell lung cancer	Adenocarcinoma	III	KRAS G12C	26	8.3	72	female	1	9	3.6	0	sotorasib 960 mg daily	47.4	true	MSS	2026-03-15T05:35:59.508579+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_569344	REC_0010624	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	23	6.2	78	female	1	8	7.2	1	alectinib 600 mg BID	20.4	false	MSS	2026-03-15T05:35:59.508840+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_958816	REC_0010625	Non-small cell lung cancer	Large cell carcinoma	IVA	None (PD-L1 high)	19	9.6	61	male	0	17	5.8	2	pembrolizumab 200 mg q3w	23.3	false	MSS	2026-03-15T05:35:59.509089+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_494807	REC_0010626	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	17	9.2	73	female	2	13	8.4	6	alectinib 600 mg BID	11.5	false	MSS	2026-03-15T05:35:59.509337+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_121824	REC_0010627	Non-small cell lung cancer	Adenocarcinoma	III	KRAS G12C	24	16.4	59	female	1	14	5.9	0	sotorasib 960 mg daily	44.5	false	MSI-H	2026-03-15T05:35:59.509599+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_867538	REC_0010628	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	20	11.9	67	female	1	20	6.5	7	sotorasib 960 mg daily	9.9	false	MSI-H	2026-03-15T05:35:59.509862+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_168398	REC_0010629	Non-small cell lung cancer	Adenocarcinoma	III	None (PD-L1 high)	26	16.1	77	female	1	16	5.2	0	pembrolizumab 200 mg q3w	31	false	MSI-H	2026-03-15T05:35:59.510106+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_550913	REC_0010630	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	21	6.5	65	male	0	50	5.7	5	carboplatin + paclitaxel + pembrolizumab	14	true	MSS	2026-03-15T05:35:59.510345+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_835935	REC_0010631	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	23	19.6	61	female	0	8	5.4	4	osimertinib 80 mg daily	8.2	true	MSI-H	2026-03-15T05:35:59.510581+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_432516	REC_0010632	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	21	5.2	71	male	2	27	5.4	7	carboplatin + paclitaxel + pembrolizumab	14.6	true	MSS	2026-03-15T05:35:59.510812+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_777209	REC_0010633	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	23	17.2	75	male	0	8	6.7	3	sotorasib 960 mg daily	15.2	false	MSS	2026-03-15T05:35:59.511054+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_292756	REC_0010634	Non-small cell lung cancer	Adenocarcinoma	IVA	None (PD-L1 high)	28	10.8	79	female	2	5	7	2	pembrolizumab 200 mg q3w	22.2	false	MSS	2026-03-15T05:35:59.511294+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_287056	REC_0010635	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	18	13.1	73	male	2	11	3.3	7	alectinib 600 mg BID	10.2	false	MSI-H	2026-03-15T05:35:59.511623+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_781559	REC_0010636	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None	27	5.6	58	male	0	33	7.3	1	carboplatin + paclitaxel + pembrolizumab	10.6	true	MSS	2026-03-15T05:35:59.511862+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_342206	REC_0010637	Non-small cell lung cancer	Adenocarcinoma	IVB	None (PD-L1 high)	21	11.4	80	female	1	11	5.3	4	pembrolizumab 200 mg q3w	6.1	true	MSS	2026-03-15T05:35:59.512146+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_352400	REC_0010638	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR L858R	24	10.5	53	female	0	18	4.1	2	osimertinib 80 mg daily	24.3	true	MSI-H	2026-03-15T05:35:59.512412+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_709756	REC_0010639	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None	24	5.3	71	female	2	35	6	2	carboplatin + paclitaxel + pembrolizumab	21.7	true	MSS	2026-03-15T05:35:59.512653+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_323020	REC_0010640	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	18	18	71	male	2	13	6.3	6	osimertinib 80 mg daily	8.8	true	MSI-H	2026-03-15T05:35:59.512892+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_848834	REC_0010641	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR exon 19 deletion	31	16.8	58	male	0	16	4.1	2	osimertinib 80 mg daily	31.4	false	MSS	2026-03-15T05:35:59.513129+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_271342	REC_0010642	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	15	12.3	70	female	1	18	4.6	1	sotorasib 960 mg daily	20.3	true	MSS	2026-03-15T05:35:59.513363+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_996329	REC_0010643	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	26	12.9	74	female	1	17	3.3	7	alectinib 600 mg BID	16.4	true	MSS	2026-03-15T05:35:59.513599+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_826173	REC_0010644	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	33	11.2	59	male	1	9	5	7	alectinib 600 mg BID	7.3	false	MSI-H	2026-03-15T05:35:59.513844+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_829256	REC_0010645	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	22	17.5	72	female	2	18	3.6	2	entrectinib 600 mg daily	20.1	false	MSI-H	2026-03-15T05:35:59.514075+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_121826	REC_0010646	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR L858R	19	10.7	68	female	1	6	5.6	1	osimertinib 80 mg daily	4.9	false	MSS	2026-03-15T05:35:59.514309+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_209017	REC_0010647	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	32	12.7	68	female	0	18	5.8	4	alectinib 600 mg BID	17.5	false	MSI-H	2026-03-15T05:35:59.514544+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_694731	REC_0010648	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	26	9.6	78	male	1	20	4.7	1	entrectinib 600 mg daily	23.6	true	MSS	2026-03-15T05:35:59.514893+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_280359	REC_0010649	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	30	13.5	67	female	1	7	4.5	6	entrectinib 600 mg daily	11.3	true	MSI-H	2026-03-15T05:35:59.515139+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_152860	REC_0010650	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	32	8.8	62	male	0	11	6.5	7	osimertinib 80 mg daily	7.8	true	MSS	2026-03-15T05:35:59.515374+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_286135	REC_0010651	Non-small cell lung cancer	Adenocarcinoma	IVA	None (PD-L1 high)	22	15.3	68	female	0	21	6.7	2	pembrolizumab 200 mg q3w	22.8	true	MSI-H	2026-03-15T05:35:59.515606+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_960758	REC_0010652	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	30	11.5	65	female	0	13	5.3	7	osimertinib 80 mg daily	15.2	true	MSS	2026-03-15T05:35:59.515842+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_130219	REC_0010653	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	26	12.8	67	female	0	10	4.7	4	alectinib 600 mg BID	11.9	false	MSS	2026-03-15T05:35:59.516122+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_808640	REC_0010654	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	25	8.3	41	female	0	14	6.1	5	osimertinib 80 mg daily	7.7	false	MSS	2026-03-15T05:35:59.516366+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_791628	REC_0010655	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None	18	7.4	64	female	1	49	5.7	2	carboplatin + paclitaxel + pembrolizumab	23.4	true	MSS	2026-03-15T05:35:59.516604+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_594537	REC_0010656	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	27	8.6	73	male	2	23	5.8	1	sotorasib 960 mg daily	27.5	true	MSS	2026-03-15T05:35:59.516845+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_357065	REC_0010657	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	24	2.6	72	female	3	6	5.1	6	carboplatin + paclitaxel + pembrolizumab	10.8	true	MSS	2026-03-15T05:35:59.517076+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_974019	REC_0010658	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR exon 19 deletion	27	15.2	53	female	0	17	5.1	1	osimertinib 80 mg daily	22.9	true	MSI-H	2026-03-15T05:35:59.517314+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_755387	REC_0010659	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	29	8.4	56	male	0	8	4.9	5	alectinib 600 mg BID	9.8	true	MSS	2026-03-15T05:35:59.517548+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_264539	REC_0010660	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	24	10.4	61	male	1	3	4.8	2	alectinib 600 mg BID	12.9	true	MSI-H	2026-03-15T05:35:59.517784+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_637077	REC_0010661	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR L858R	27	16.7	60	male	0	8	6.3	1	osimertinib 80 mg daily	13.4	false	MSS	2026-03-15T05:35:59.518099+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_888150	REC_0010662	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	21	12.1	51	male	0	7	7.3	5	osimertinib 80 mg daily	6.9	true	MSI-H	2026-03-15T05:35:59.518345+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_734139	REC_0010663	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	15	12.9	71	female	0	9	4.7	9	sotorasib 960 mg daily	10.8	false	MSS	2026-03-15T05:35:59.518580+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_749478	REC_0010664	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None (PD-L1 high)	18	6.3	69	female	1	79	4.6	2	pembrolizumab 200 mg q3w	13.4	true	MSS	2026-03-15T05:35:59.518819+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_359061	REC_0010665	Non-small cell lung cancer	Large cell carcinoma	IVB	None (PD-L1 high)	28	5.9	76	female	1	6	5.8	5	pembrolizumab 200 mg q3w	15.4	true	MSS	2026-03-15T05:35:59.519059+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_658244	REC_0010666	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	30	13.6	50	male	0	11	5.8	1	sotorasib 960 mg daily	26	true	MSS	2026-03-15T05:35:59.519296+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_358423	REC_0010667	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	23	10.1	62	male	0	19	4.5	3	osimertinib 80 mg daily	5.5	true	MSI-H	2026-03-15T05:35:59.519530+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_531849	REC_0010668	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	25	12.5	54	male	0	7	4.3	4	entrectinib 600 mg daily	5.2	false	MSS	2026-03-15T05:35:59.519761+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_258566	REC_0010669	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None	25	6.8	65	female	0	78	6	1	carboplatin + paclitaxel + pembrolizumab	21.7	false	MSS	2026-03-15T05:35:59.519993+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_733559	REC_0010670	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	18	9.1	53	female	0	13	6.5	5	osimertinib 80 mg daily	19.6	true	MSS	2026-03-15T05:35:59.520267+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_391584	REC_0010671	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	22	5.2	65	female	1	102	6.4	5	carboplatin + paclitaxel + pembrolizumab	13.5	false	MSS	2026-03-15T05:35:59.520503+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_382967	REC_0010672	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	18	9.9	75	female	1	9	4.5	6	entrectinib 600 mg daily	8	false	MSS	2026-03-15T05:35:59.520736+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_164185	REC_0010673	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	26	3.8	64	male	0	12	4.7	4	sotorasib 960 mg daily	9.3	false	MSS	2026-03-15T05:35:59.520969+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_970149	REC_0010674	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	16	4.6	58	male	0	52	5	5	carboplatin + paclitaxel + pembrolizumab	8.5	false	MSS	2026-03-15T05:35:59.521275+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_920007	REC_0010675	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None (PD-L1 high)	27	4.2	67	female	1	72	4.8	6	pembrolizumab 200 mg q3w	21.1	true	MSS	2026-03-15T05:35:59.521511+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_995130	REC_0010676	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR L858R	21	13.4	54	male	0	19	7.8	1	osimertinib 80 mg daily	19.3	false	MSI-H	2026-03-15T05:35:59.521752+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_160679	REC_0010677	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR L858R	33	16.9	72	male	2	17	6	1	osimertinib 80 mg daily	4	true	MSI-H	2026-03-15T05:35:59.521994+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_935018	REC_0010678	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None	18	8.1	78	female	1	30	5.7	1	carboplatin + paclitaxel + pembrolizumab	17.8	true	MSS	2026-03-15T05:35:59.522221+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_342259	REC_0010679	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	30	17.4	56	female	1	15	7.5	5	alectinib 600 mg BID	7.6	false	MSI-H	2026-03-15T05:35:59.522460+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_606909	REC_0010680	Non-small cell lung cancer	Adenocarcinoma	III	KRAS G12C	24	14.5	75	female	3	22	7.3	0	sotorasib 960 mg daily	32.8	false	MSI-H	2026-03-15T05:35:59.522703+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_431199	REC_0010681	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	25	18	64	male	0	15	5.3	5	sotorasib 960 mg daily	4	true	MSI-H	2026-03-15T05:35:59.522939+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_451579	REC_0010682	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	23	10.3	58	male	1	10	4.9	2	sotorasib 960 mg daily	10.7	true	MSS	2026-03-15T05:35:59.523173+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_342815	REC_0010683	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None (PD-L1 high)	23	9	61	female	0	52	6.4	1	pembrolizumab 200 mg q3w	25.1	true	MSS	2026-03-15T05:35:59.523407+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_677593	REC_0010684	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None	22	9.4	60	male	1	54	5.6	1	carboplatin + paclitaxel + pembrolizumab	14	false	MSS	2026-03-15T05:35:59.523646+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_356458	REC_0010685	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	15	15.2	70	female	0	13	6.3	2	entrectinib 600 mg daily	12.1	true	MSS	2026-03-15T05:35:59.523876+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_270963	REC_0010686	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	21	16.6	69	female	1	14	4.7	5	osimertinib 80 mg daily	12.2	true	MSI-H	2026-03-15T05:35:59.524137+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_735589	REC_0010687	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	28	12.6	63	female	0	27	3.9	5	entrectinib 600 mg daily	8.2	false	MSI-H	2026-03-15T05:35:59.524455+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_513621	REC_0010688	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None (PD-L1 high)	22	7.7	79	male	1	33	6.1	2	pembrolizumab 200 mg q3w	15.6	true	MSS	2026-03-15T05:35:59.524742+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_799603	REC_0010689	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	23	13.4	66	male	0	19	7.2	2	alectinib 600 mg BID	22.2	true	MSS	2026-03-15T05:35:59.525028+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_887144	REC_0010690	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	30	12.9	62	male	0	24	5	2	sotorasib 960 mg daily	13.4	true	MSI-H	2026-03-15T05:35:59.525420+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_947279	REC_0010691	Non-small cell lung cancer	Adenocarcinoma	III	ALK fusion	16	5.9	70	female	1	13	4.6	0	alectinib 600 mg BID	58.7	false	MSS	2026-03-15T05:35:59.525669+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_818508	REC_0010692	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR exon 19 deletion	11	9.1	79	female	1	8	4.6	2	osimertinib 80 mg daily	25.5	true	MSS	2026-03-15T05:35:59.525906+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_608083	REC_0010693	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	13	8.7	69	female	1	19	5.2	7	entrectinib 600 mg daily	16.7	false	MSS	2026-03-15T05:35:59.526149+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_928673	REC_0010694	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	25	12.2	67	female	0	7	6.3	2	sotorasib 960 mg daily	22.9	false	MSS	2026-03-15T05:35:59.526488+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_193994	REC_0010695	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	20	7.7	70	female	2	24	7	6	alectinib 600 mg BID	11.9	false	MSS	2026-03-15T05:35:59.526719+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_190806	REC_0010696	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	22	13.6	61	female	0	15	5.6	4	sotorasib 960 mg daily	17.2	false	MSS	2026-03-15T05:35:59.526961+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_636386	REC_0010697	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	18	8.2	65	male	0	32	3.7	4	carboplatin + paclitaxel + pembrolizumab	9.2	false	MSS	2026-03-15T05:35:59.527193+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_205789	REC_0010698	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR exon 19 deletion	21	13.8	69	female	0	11	5.3	2	osimertinib 80 mg daily	16.8	true	MSS	2026-03-15T05:35:59.527429+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_313754	REC_0010699	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	24	5.4	74	female	1	31	5.7	6	carboplatin + paclitaxel + pembrolizumab	16	true	MSS	2026-03-15T05:35:59.527657+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_830101	REC_0010700	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	22	16.4	67	female	0	19	5.9	6	entrectinib 600 mg daily	11.4	true	MSS	2026-03-15T05:35:59.527995+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_843269

REC_0010601

Non-small cell lung cancer

Large cell carcinoma

IVB

None (PD-L1 high)

30

5.8

65

female

1

12

3.8

9

pembrolizumab 200 mg q3w

9

true

MSS

2026-03-15T05:35:59.503138+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_396741

REC_0010602

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None (PD-L1 high)

17

7.6

64

female

1

56

6.7

4

pembrolizumab 200 mg q3w

11

false

MSS

2026-03-15T05:35:59.503368+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_266026

REC_0010603

Non-small cell lung cancer

Adenocarcinoma

III

ROS1 fusion

29

14

77

female

2

19

6.6

0

entrectinib 600 mg daily

31

true

MSS

2026-03-15T05:35:59.503604+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_697448

REC_0010604

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

20

10.3

63

male

1

14

5.2

6

sotorasib 960 mg daily

13.5

true

MSI-H

2026-03-15T05:35:59.503837+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_769368

REC_0010605

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

21

4.7

76

female

2

56

5.3

5

carboplatin + paclitaxel + pembrolizumab

4

true

MSS

2026-03-15T05:35:59.504109+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_969638

REC_0010606

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

20

16.9

73

male

2

23

5.2

6

osimertinib 80 mg daily

18.5

false

MSS

2026-03-15T05:35:59.504359+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_904395

REC_0010607

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

21

2.2

58

male

1

49

7

5

carboplatin + paclitaxel + pembrolizumab

11.1

false

MSS

2026-03-15T05:35:59.504598+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_428188

REC_0010608

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

18

6.6

69

female

1

0

6.9

5

entrectinib 600 mg daily

4.3

true

MSS

2026-03-15T05:35:59.504828+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_902621

REC_0010609

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

23

5.5

57

female

0

9

3.5

4

sotorasib 960 mg daily

11.6

true

MSS

2026-03-15T05:35:59.505142+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_522168

REC_0010610

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

24

17.6

68

male

1

21

6.2

1

alectinib 600 mg BID

19.4

false

MSS

2026-03-15T05:35:59.505383+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_761163

REC_0010611

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

21

14.8

73

female

1

13

3.8

4

osimertinib 80 mg daily

9.9

false

MSS

2026-03-15T05:35:59.505617+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_786217

REC_0010612

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

31

13.4

76

female

1

13

3.1

2

alectinib 600 mg BID

23.6

false

MSI-H

2026-03-15T05:35:59.505849+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_334661

REC_0010613

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

22

16.6

68

female

0

9

4.5

7

sotorasib 960 mg daily

12.7

false

MSS

2026-03-15T05:35:59.506087+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_752777

REC_0010614

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None

31

7.9

68

female

1

21

6

2

carboplatin + paclitaxel + pembrolizumab

11.7

false

MSS

2026-03-15T05:35:59.506316+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_506795

REC_0010615

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

29

16.1

67

female

0

14

7

4

osimertinib 80 mg daily

4

false

MSI-H

2026-03-15T05:35:59.506550+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_618129

REC_0010616

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

13

8.6

68

female

0

14

4.6

1

entrectinib 600 mg daily

22.1

true

MSS

2026-03-15T05:35:59.506780+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_666622

REC_0010617

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

18

11

75

male

2

4

7

5

sotorasib 960 mg daily

17.8

false

MSS

2026-03-15T05:35:59.507019+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_217721

REC_0010618

Non-small cell lung cancer

Adenocarcinoma

IVB

None (PD-L1 high)

17

11.7

47

female

0

21

5

7

pembrolizumab 200 mg q3w

14.1

false

MSI-H

2026-03-15T05:35:59.507251+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_859997

REC_0010619

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None (PD-L1 high)

32

6.6

71

male

0

34

6.9

5

pembrolizumab 200 mg q3w

17.8

true

MSS

2026-03-15T05:35:59.507483+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_400945

REC_0010620

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

28

14.7

68

female

1

28

4.2

2

entrectinib 600 mg daily

18.3

false

MSS

2026-03-15T05:35:59.507716+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_967130

REC_0010621

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

19

15.8

74

female

1

11

5.7

3

sotorasib 960 mg daily

15.2

false

MSI-H

2026-03-15T05:35:59.507950+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_966498

REC_0010622

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR L858R

21

14.9

68

female

0

16

5

1

osimertinib 80 mg daily

12.1

true

MSI-H

2026-03-15T05:35:59.508317+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_578510

REC_0010623

Non-small cell lung cancer

Adenocarcinoma

III

KRAS G12C

26

8.3

72

female

1

9

3.6

0

sotorasib 960 mg daily

47.4

true

MSS

2026-03-15T05:35:59.508579+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_569344

REC_0010624

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

23

6.2

78

female

1

8

7.2

1

alectinib 600 mg BID

20.4

false

MSS

2026-03-15T05:35:59.508840+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_958816

REC_0010625

Non-small cell lung cancer

Large cell carcinoma

IVA

None (PD-L1 high)

19

9.6

61

male

0

17

5.8

2

pembrolizumab 200 mg q3w

23.3

false

MSS

2026-03-15T05:35:59.509089+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_494807

REC_0010626

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

17

9.2

73

female

2

13

8.4

6

alectinib 600 mg BID

11.5

false

MSS

2026-03-15T05:35:59.509337+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_121824

REC_0010627

Non-small cell lung cancer

Adenocarcinoma

III

KRAS G12C

24

16.4

59

female

1

14

5.9

0

sotorasib 960 mg daily

44.5

false

MSI-H

2026-03-15T05:35:59.509599+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_867538

REC_0010628

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

20

11.9

67

female

1

20

6.5

7

sotorasib 960 mg daily

9.9

false

MSI-H

2026-03-15T05:35:59.509862+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_168398

REC_0010629

Non-small cell lung cancer

Adenocarcinoma

III

None (PD-L1 high)

26

16.1

77

female

1

16

5.2

0

pembrolizumab 200 mg q3w

31

false

MSI-H

2026-03-15T05:35:59.510106+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_550913

REC_0010630

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

21

6.5

65

male

0

50

5.7

5

carboplatin + paclitaxel + pembrolizumab

14

true

MSS

2026-03-15T05:35:59.510345+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_835935

REC_0010631

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

23

19.6

61

female

0

8

5.4

4

osimertinib 80 mg daily

8.2

true

MSI-H

2026-03-15T05:35:59.510581+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_432516

REC_0010632

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

21

5.2

71

male

2

27

5.4

7

carboplatin + paclitaxel + pembrolizumab

14.6

true

MSS

2026-03-15T05:35:59.510812+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_777209

REC_0010633

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

23

17.2

75

male

0

8

6.7

3

sotorasib 960 mg daily

15.2

false

MSS

2026-03-15T05:35:59.511054+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_292756

REC_0010634

Non-small cell lung cancer

Adenocarcinoma

IVA

None (PD-L1 high)

28

10.8

79

female

2

5

7

2

pembrolizumab 200 mg q3w

22.2

false

MSS

2026-03-15T05:35:59.511294+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_287056

REC_0010635

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

18

13.1

73

male

2

11

3.3

7

alectinib 600 mg BID

10.2

false

MSI-H

2026-03-15T05:35:59.511623+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_781559

REC_0010636

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None

27

5.6

58

male

0

33

7.3

1

carboplatin + paclitaxel + pembrolizumab

10.6

true

MSS

2026-03-15T05:35:59.511862+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_342206

REC_0010637

Non-small cell lung cancer

Adenocarcinoma

IVB

None (PD-L1 high)

21

11.4

80

female

1

11

5.3

4

pembrolizumab 200 mg q3w

6.1

true

MSS

2026-03-15T05:35:59.512146+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_352400

REC_0010638

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR L858R

24

10.5

53

female

0

18

4.1

2

osimertinib 80 mg daily

24.3

true

MSI-H

2026-03-15T05:35:59.512412+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_709756

REC_0010639

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None

24

5.3

71

female

2

35

6

2

carboplatin + paclitaxel + pembrolizumab

21.7

true

MSS

2026-03-15T05:35:59.512653+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_323020

REC_0010640

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

18

71

male

2

13

6.3

6

osimertinib 80 mg daily

8.8

true

MSI-H

2026-03-15T05:35:59.512892+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_848834

REC_0010641

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR exon 19 deletion

31

16.8

58

male

0

16

4.1

2

osimertinib 80 mg daily

31.4

false

MSS

2026-03-15T05:35:59.513129+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_271342

REC_0010642

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

15

12.3

70

female

1

18

4.6

1

sotorasib 960 mg daily

20.3

true

MSS

2026-03-15T05:35:59.513363+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_996329

REC_0010643

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

26

12.9

74

female

1

17

3.3

7

alectinib 600 mg BID

16.4

true

MSS

2026-03-15T05:35:59.513599+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_826173

REC_0010644

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

33

11.2

59

male

1

9

5

7

alectinib 600 mg BID

7.3

false

MSI-H

2026-03-15T05:35:59.513844+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_829256

REC_0010645

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

22

17.5

72

female

2

18

3.6

2

entrectinib 600 mg daily

20.1

false

MSI-H

2026-03-15T05:35:59.514075+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_121826

REC_0010646

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR L858R

19

10.7

68

female

1

6

5.6

1

osimertinib 80 mg daily

4.9

false

MSS

2026-03-15T05:35:59.514309+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_209017

REC_0010647

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

32

12.7

68

female

0

18

5.8

4

alectinib 600 mg BID

17.5

false

MSI-H

2026-03-15T05:35:59.514544+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_694731

REC_0010648

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

26

9.6

78

male

1

20

4.7

1

entrectinib 600 mg daily

23.6

true

MSS

2026-03-15T05:35:59.514893+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_280359

REC_0010649

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

30

13.5

67

female

1

7

4.5

6

entrectinib 600 mg daily

11.3

true

MSI-H

2026-03-15T05:35:59.515139+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_152860

REC_0010650

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

32

8.8

62

male

0

11

6.5

7

osimertinib 80 mg daily

7.8

true

MSS

2026-03-15T05:35:59.515374+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_286135

REC_0010651

Non-small cell lung cancer

Adenocarcinoma

IVA

None (PD-L1 high)

22

15.3

68

female

0

21

6.7

2

pembrolizumab 200 mg q3w

22.8

true

MSI-H

2026-03-15T05:35:59.515606+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_960758

REC_0010652

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

30

11.5

65

female

0

13

5.3

7

osimertinib 80 mg daily

15.2

true

MSS

2026-03-15T05:35:59.515842+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_130219

REC_0010653

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

26

12.8

67

female

0

10

4.7

4

alectinib 600 mg BID

11.9

false

MSS

2026-03-15T05:35:59.516122+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_808640

REC_0010654

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

25

8.3

41

female

0

14

6.1

5

osimertinib 80 mg daily

7.7

false

MSS

2026-03-15T05:35:59.516366+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_791628

REC_0010655

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None

18

7.4

64

female

1

49

5.7

2

carboplatin + paclitaxel + pembrolizumab

23.4

true

MSS

2026-03-15T05:35:59.516604+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_594537

REC_0010656

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

27

8.6

73

male

2

23

5.8

1

sotorasib 960 mg daily

27.5

true

MSS

2026-03-15T05:35:59.516845+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_357065

REC_0010657

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

24

2.6

72

female

3

6

5.1

6

carboplatin + paclitaxel + pembrolizumab

10.8

true

MSS

2026-03-15T05:35:59.517076+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_974019

REC_0010658

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR exon 19 deletion

27

15.2

53

female

0

17

5.1

1

osimertinib 80 mg daily

22.9

true

MSI-H

2026-03-15T05:35:59.517314+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_755387

REC_0010659

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

29

8.4

56

male

0

8

4.9

5

alectinib 600 mg BID

9.8

true

MSS

2026-03-15T05:35:59.517548+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_264539

REC_0010660

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

24

10.4

61

male

1

3

4.8

2

alectinib 600 mg BID

12.9

true

MSI-H

2026-03-15T05:35:59.517784+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_637077

REC_0010661

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR L858R

27

16.7

60

male

0

8

6.3

1

osimertinib 80 mg daily

13.4

false

MSS

2026-03-15T05:35:59.518099+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_888150

REC_0010662

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

21

12.1

51

male

0

7

7.3

5

osimertinib 80 mg daily

6.9

true

MSI-H

2026-03-15T05:35:59.518345+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_734139

REC_0010663

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

15

12.9

71

female

0

9

4.7

9

sotorasib 960 mg daily

10.8

false

MSS

2026-03-15T05:35:59.518580+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_749478

REC_0010664

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None (PD-L1 high)

18

6.3

69

female

1

79

4.6

2

pembrolizumab 200 mg q3w

13.4

true

MSS

2026-03-15T05:35:59.518819+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_359061

REC_0010665

Non-small cell lung cancer

Large cell carcinoma

IVB

None (PD-L1 high)

28

5.9

76

female

1

6

5.8

5

pembrolizumab 200 mg q3w

15.4

true

MSS

2026-03-15T05:35:59.519059+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_658244

REC_0010666

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

30

13.6

50

male

0

11

5.8

1

sotorasib 960 mg daily

26

true

MSS

2026-03-15T05:35:59.519296+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_358423

REC_0010667

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

23

10.1

62

male

0

19

4.5

3

osimertinib 80 mg daily

5.5

true

MSI-H

2026-03-15T05:35:59.519530+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_531849

REC_0010668

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

25

12.5

54

male

0

7

4.3

4

entrectinib 600 mg daily

5.2

false

MSS

2026-03-15T05:35:59.519761+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_258566

REC_0010669

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None

25

6.8

65

female

0

78

6

1

carboplatin + paclitaxel + pembrolizumab

21.7

false

MSS

2026-03-15T05:35:59.519993+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_733559

REC_0010670

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

18

9.1

53

female

0

13

6.5

5

osimertinib 80 mg daily

19.6

true

MSS

2026-03-15T05:35:59.520267+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_391584

REC_0010671

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

22

5.2

65

female

1

102

6.4

5

carboplatin + paclitaxel + pembrolizumab

13.5

false

MSS

2026-03-15T05:35:59.520503+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_382967

REC_0010672

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

18

9.9

75

female

1

9

4.5

6

entrectinib 600 mg daily

8

false

MSS

2026-03-15T05:35:59.520736+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_164185

REC_0010673

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

26

3.8

64

male

0

12

4.7

4

sotorasib 960 mg daily

9.3

false

MSS

2026-03-15T05:35:59.520969+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_970149

REC_0010674

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

16

4.6

58

male

0

52

5

carboplatin + paclitaxel + pembrolizumab

8.5

false

MSS

2026-03-15T05:35:59.521275+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_920007

REC_0010675

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None (PD-L1 high)

27

4.2

67

female

1

72

4.8

6

pembrolizumab 200 mg q3w

21.1

true

MSS

2026-03-15T05:35:59.521511+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_995130

REC_0010676

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR L858R

21

13.4

54

male

0

19

7.8

1

osimertinib 80 mg daily

19.3

false

MSI-H

2026-03-15T05:35:59.521752+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_160679

REC_0010677

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR L858R

33

16.9

72

male

2

17

6

1

osimertinib 80 mg daily

4

true

MSI-H

2026-03-15T05:35:59.521994+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_935018

REC_0010678

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None

18

8.1

78

female

1

30

5.7

1

carboplatin + paclitaxel + pembrolizumab

17.8

true

MSS

2026-03-15T05:35:59.522221+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_342259

REC_0010679

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

30

17.4

56

female

1

15

7.5

5

alectinib 600 mg BID

7.6

false

MSI-H

2026-03-15T05:35:59.522460+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_606909

REC_0010680

Non-small cell lung cancer

Adenocarcinoma

III

KRAS G12C

24

14.5

75

female

3

22

7.3

0

sotorasib 960 mg daily

32.8

false

MSI-H

2026-03-15T05:35:59.522703+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_431199

REC_0010681

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

25

18

64

male

0

15

5.3

5

sotorasib 960 mg daily

4

true

MSI-H

2026-03-15T05:35:59.522939+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_451579

REC_0010682

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

23

10.3

58

male

1

10

4.9

2

sotorasib 960 mg daily

10.7

true

MSS

2026-03-15T05:35:59.523173+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_342815

REC_0010683

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None (PD-L1 high)

23

9

61

female

0

52

6.4

1

pembrolizumab 200 mg q3w

25.1

true

MSS

2026-03-15T05:35:59.523407+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_677593

REC_0010684

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None

22

9.4

60

male

1

54

5.6

1

carboplatin + paclitaxel + pembrolizumab

14

false

MSS

2026-03-15T05:35:59.523646+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_356458

REC_0010685

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

15

15.2

70

female

0

13

6.3

2

entrectinib 600 mg daily

12.1

true

MSS

2026-03-15T05:35:59.523876+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_270963

REC_0010686

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

21

16.6

69

female

1

14

4.7

5

osimertinib 80 mg daily

12.2

true

MSI-H

2026-03-15T05:35:59.524137+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_735589

REC_0010687

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

28

12.6

63

female

0

27

3.9

5

entrectinib 600 mg daily

8.2

false

MSI-H

2026-03-15T05:35:59.524455+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_513621

REC_0010688

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None (PD-L1 high)

22

7.7

79

male

1

33

6.1

2

pembrolizumab 200 mg q3w

15.6

true

MSS

2026-03-15T05:35:59.524742+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_799603

REC_0010689

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

23

13.4

66

male

0

19

7.2

2

alectinib 600 mg BID

22.2

true

MSS

2026-03-15T05:35:59.525028+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_887144

REC_0010690

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

30

12.9

62

male

0

24

5

2

sotorasib 960 mg daily

13.4

true

MSI-H

2026-03-15T05:35:59.525420+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_947279

REC_0010691

Non-small cell lung cancer

Adenocarcinoma

III

ALK fusion

16

5.9

70

female

1

13

4.6

0

alectinib 600 mg BID

58.7

false

MSS

2026-03-15T05:35:59.525669+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_818508

REC_0010692

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR exon 19 deletion

11

9.1

79

female

1

8

4.6

2

osimertinib 80 mg daily

25.5

true

MSS

2026-03-15T05:35:59.525906+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_608083

REC_0010693

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

13

8.7

69

female

1

19

5.2

7

entrectinib 600 mg daily

16.7

false

MSS

2026-03-15T05:35:59.526149+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_928673

REC_0010694

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

25

12.2

67

female

0

7

6.3

2

sotorasib 960 mg daily

22.9

false

MSS

2026-03-15T05:35:59.526488+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_193994

REC_0010695

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

20

7.7

70

female

2

24

7

6

alectinib 600 mg BID

11.9

false

MSS

2026-03-15T05:35:59.526719+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_190806

REC_0010696

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

22

13.6

61

female

0

15

5.6

4

sotorasib 960 mg daily

17.2

false

MSS

2026-03-15T05:35:59.526961+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_636386

REC_0010697

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

18

8.2

65

male

0

32

3.7

4

carboplatin + paclitaxel + pembrolizumab

9.2

false

MSS

2026-03-15T05:35:59.527193+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_205789

REC_0010698

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR exon 19 deletion

21

13.8

69

female

0

11

5.3

2

osimertinib 80 mg daily

16.8

true

MSS

2026-03-15T05:35:59.527429+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_313754

REC_0010699

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

24

5.4

74

female

1

31

5.7

6

carboplatin + paclitaxel + pembrolizumab

16

true

MSS

2026-03-15T05:35:59.527657+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_830101

REC_0010700

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

22

16.4

67

female

0

19

5.9

6

entrectinib 600 mg daily

11.4

true

MSS

2026-03-15T05:35:59.527995+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)